Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 69.03M
47.55x6.7x-0.76x5.41x22.88x30.66x2.6% 318B
24.01x2.01x-14.98x3.29x11.74x19.38x1.65% 70.43B
12.12x12.82x0.07x6.13x9.44x10.37x - 9.68B
17.64x1.52x0.87x2.25x7.75x9.25x2.53% 8.78B
22.65x6.02x2.27x6.45x18.23x19.06x-.--% 4.39B
34.65x - 0.22x6.55x18.74x30.36x - 4.01B
39.03x2.33x-1.27x2.21x27.2x41.06x0.79% 3.46B
110.63x - -0.68x - - - -.--% 2.78B
17.23x0.75x-0.63x1.35x24.1x41.26x4.11% 1.06B
52.18x - -0.1x - - - - 1.03B
-7.48x12.33x0.48x205.57x-6.66x-5.2x-.--% 972M
Average 33.65x 5.56x -1.32x 26.58x 14.82x 21.80x 1.46% 35.41B
Weighted average by Cap. 42.00x 5.89x -3.02x 5.45x 20.28x 27.76x 2.37%
Specialty & Advanced Pharmaceuticals